Galaxy Life Sciences Retains MidPoint Engineering to Commence Design Services for New Biomanufacturing Facility at The Reactory

Galaxy Life Sciences, LLC (Galaxy) has retained MidPoint Engineering [...]

By |2021-08-31T17:07:44+00:00August 31st, 2021|In the press, Reactory|0 Comments

Trump To Sign Executive Order Requiring U.S. To Buy ‘Essential’ Drugs From American Companies

CNBC - August 2020
President Donald Trump will sign an executive order requiring the U.S. government to buy “essential” drugs from American companies, White House trade advisor Peter Navarro announced Thursday. Learn More

By |2020-08-07T16:35:01+00:00August 6th, 2020|In the press, Latest Publications|0 Comments

White House Preparing Executive Order Requiring Certain Essential Drugs Be Made In U.S., Sources Say

CNBC - May 2020
The White House is preparing an executive order which will require certain essential drugs be made in the U.S. Learn More

By |2020-05-15T20:42:21+00:00May 15th, 2020|In the press, Latest Publications|0 Comments

Tax Deal Endorsed For $60 million WuXi Biologics Project In Worcester

Worcester Telegram - March 2020
The City Council Economic Development Committee Monday night unanimously endorsed a 20-year tax increment financing plan for the project that would save the company roughly $11.5 million in property taxes over the life of the plan. During that period, the city would receive $20.7 million in new tax revenue from the project. Learn More

By |2020-05-16T17:02:52+00:00March 16th, 2020|In the press, Latest Publications|0 Comments

Industry Veteran Matthew Zicaro Joins Development Firm to Form Galaxy Life Sciences

January 2020
Zicaro will lead team efforts in the acquisition, design, construction and leasing of state-of-the-art facilities supporting biopharmaceutical research, development, and manufacturing operations. Learn More

By |2020-12-10T20:20:18+00:00November 2nd, 2017|In the press, Latest Publications|0 Comments
Go to Top